October 4, 2019European Journal of Preventive Cardiology
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings
Why the study?
Cardiac amyloidosis remains misdiagnosed and underdiagnosed despite available life-saving treatments, creating a need to increase awareness and provide a guide to screening and early diagnosis through recognition of clinical, laboratory, and imaging red flags.
Structured PICO
P
Population
Patients with suspected or confirmed cardiac amyloidosis (immunoglobulin light-chain or transthyretin amyloidosis)
I
Intervention
Screening and early diagnosis using clinical, laboratory, and imaging 'red flags'
Early recognition of clinical, laboratory, and imaging red flags is crucial for the timely diagnosis and initiation of life-saving therapies in cardiac amyloidosis.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Remains underdiagnosed despite available therapies improving survival; leaves open optimal screening strategies in systemic amyloidosis.
Cite This Study
Vergaro et al. (2019) studied this question.